Newsroom

OTTAWA, Ontario--(BUSINESS WIRE)--Porter Airlines is inaugurating service between Ottawa International Airport (YOW) and Deer Lake Regional Airport (YDF) today, becoming the only airline to connect the two destinations with non-stop flights. The seasonal route starts with four weekly roundtrips and ends in early September. The Embraer E195-E2 aircraft used for these flights carries up to 132 passengers, and with a two-by-two configuration, there are no middle seats on any flight. All of Porter’...

OTTAWA--(BUSINESS WIRE)--Porter Airlines inaugure aujourd’hui le service entre l’aéroport international d’Ottawa (YOW) et l’aéroport régional de Deer Lake (YDF), devenant ainsi la seule compagnie aérienne à relier les deux destinations par des vols sans escale. Cet itinéraire saisonnier commence par quatre allers-retours par semaine et sera offert jusqu’au début septembre. L’aéronef Embraer E195-E2 utilisé pour ces vols peut transporter jusqu’à 132 passagers. Grâce à une configuration deux par...

LONDON--(BUSINESS WIRE)--Netflix is forecast to reach nearly 400 million subscribers worldwide by the end of 2031, reinforcing its position as the world’s leading subscription streaming platform despite growing consolidation across the industry. New forecasts from Omdia presented at NEM Dubrovnik 2026 indicate that scale, profitability and audience reach will increasingly shape the next phase of streaming competition. Omdia’s forecasts highlighted Netflix's continued expansion despite increasin...

SUNNYVALE, Calif.--(BUSINESS WIRE)--Coram AI raises $35M Series B to power its AI-native physical security platform, helping organizations identify risks earlier and investigate faster....

BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced that the first patient has been dosed in the Phase 1, first-in-human trial of IM-1617, a potential first-in-class ADC directed at an undisclosed solid tumor target and incorporating HC74, Immunome’s proprietary TOP1 inhibitor payload. “The first patient dosed with IM-1617 is a significant milestone for Immunom...

TORONTO--(BUSINESS WIRE)--NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), operates one of Canada’s largest networks of community-based, multidisciplinary medical facilities focused on the assessment and treatment of chronic pain, musculoskeletal/back pain, sports medicine and other pain medical services, today announced the voting results from its Annual General and Special Meeting of Shareholders (the “Meeting”) held on June 10, 2026 and the grant of restricted share units (“RSU...

LONDON--(BUSINESS WIRE)--Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage biotechnology company developing novel siRNA (short interfering RNA) therapies, today presented follow-up and quality-of-life data from the Phase 1 SANRECO study evaluating divesiran, a first-in-class siRNA therapy targeting TMPRSS6, in 21 phlebotomy-dependent patients with polycythemia vera (PV) at the European Hematology Association (EHA) 2026 Annual Congress. Divesiran data presented at EHA show improvem...

MINNEAPOLIS--(BUSINESS WIRE)--Yukon Partners is pleased to announce the promotion of Adam Moorse to Director....

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 10.06.2026 UINC IE00BZBW4Z27 10,142,690.00 USD 397,450,364.67 39.186  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 10.06.2026 UNCU.LN IE00BD6GCF16 810,851.00 USD 38,165,243.72 47.068  ...